FDA Inspection 1102691 - Boehringer Ingelheim Pharma Gmbh & Co Kg - September 19, 2019

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharma Gmbh & Co Kg, with an inspection on September 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Pharma Gmbh & Co Kg
Inspection Date: September 19, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · db6a02f0-3ebc-4c6a-b689-a50299bdaa08

Violation Codes3

21 CFR 211.100(b)21 CFR 211.113(b)21 CFR 211.192

Full citation text and observation details available on the Dashboard.